Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Hammer

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|March 16, 2011
Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trialsPeter B Gilbert, James O Berger, Donald Stablein, et al.
Transgender Health|July 14, 2020
Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State AreaNicholas Kenji Taylor, Maria R Young, Van Don Williams, et al.
Plos One|October 23, 2013
207-nm UV light - a promising tool for safe low-cost reduction of surgical site infections. I: in vitro studiesManuela Buonanno, Gerhard Randers-Pehrson, Alan W Bigelow, et al.
Clinical Trials (London, England)|April 9, 2015
Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trialLiza Dawson, Sam Garner, Chuka Anude, et al.
AIDS Research and Human Retroviruses|November 6, 2009
Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in ThailandHong Van Tieu, Jintanat Ananworanich, Anchalee Avihingsanon, et al.
Antiviral Therapy|September 13, 2006
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)Barbara M Gripshover, Heather Ribaudo, Jorge Santana, et al.
AIDS Patient Care and Stds|May 21, 2014
Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherenceBarbara S Taylor, Emily Reyes, Elizabeth A Levine, et al.
Statistical Communications in Infectious Diseases|November 28, 2012
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensPeter B Gilbert, Douglas Grove, Erin Gabriel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current EvidenceBrett Hanscom, Holly E Janes, Peter D Guarino, et al.
The Journal of Infectious Diseases|January 28, 2010
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patientsElias K Halvas, Ann Wiegand, Valerie F Boltz, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|March 16, 2011
Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trialsPeter B Gilbert, James O Berger, Donald Stablein, et al.
Transgender Health|July 14, 2020
Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State AreaNicholas Kenji Taylor, Maria R Young, Van Don Williams, et al.
Plos One|October 23, 2013
207-nm UV light - a promising tool for safe low-cost reduction of surgical site infections. I: in vitro studiesManuela Buonanno, Gerhard Randers-Pehrson, Alan W Bigelow, et al.
Clinical Trials (London, England)|April 9, 2015
Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trialLiza Dawson, Sam Garner, Chuka Anude, et al.
AIDS Research and Human Retroviruses|November 6, 2009
Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in ThailandHong Van Tieu, Jintanat Ananworanich, Anchalee Avihingsanon, et al.
Antiviral Therapy|September 13, 2006
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)Barbara M Gripshover, Heather Ribaudo, Jorge Santana, et al.
AIDS Patient Care and Stds|May 21, 2014
Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherenceBarbara S Taylor, Emily Reyes, Elizabeth A Levine, et al.
Statistical Communications in Infectious Diseases|November 28, 2012
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensPeter B Gilbert, Douglas Grove, Erin Gabriel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current EvidenceBrett Hanscom, Holly E Janes, Peter D Guarino, et al.
The Journal of Infectious Diseases|January 28, 2010
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patientsElias K Halvas, Ann Wiegand, Valerie F Boltz, et al.
Pageof 9